We spoke to new Sterling Energy CEO Tony Hawkins about the latest changes happening at the company. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,212.20
Bid: 1,212.20
Ask: 1,212.40
Change: -0.80 (-0.07%)
Spread: 0.20 (0.02%)
Open: 1,215.00
High: 1,220.40
Low: 1,204.80
Yest. Close: 1,213.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

London midday: Stocks bounce back after recent sell-off

UK markets were registering impressive gains on Tuesday morning with hopes of continued monetary easing in the Eurozone lifting sentiment as stocks bounced back following last week's sharp sell-off. After reaching a 13-year high on Wednesday, the FTSE 100 dropped sharply in the latter part of last

28 May 13 11:20

UPDATE 2-AstraZeneca buys heart firm Omthera for up to $443 mln

* AstraZeneca paying $12.70/share plus CVR worth up to $4.70 * Deal at 88 percent premium; Omthera shares at $12.80 in premarket * Fish oil-based drug builds up AstraZeneca's heart business * AZ shares up 3.2 pct, helped by generic asthma drug delay By Ben Hirschler

28 May 13 11:05

London open: Stocks surge as markets play catch up after long weekend

UK markets surged in early trading on Tuesday with traders wasting no time in playing catch up as they returned to their desks following the three-day weekend. After reaching a 13-year high on Wednesday, the FTSE 100 dropped sharply in the latter part of last week on fears of a scaling back of stim

28 May 13 08:30

STOCKS NEWS EUROPE-GlaxoSmithKline rises as DB ups to "buy"

Shares in drugmaker GlaxoSmithKline rise 2.9 percent, rallying towards the top of the FTSE 100 leaderboard, with traders citing an upgrade by Deutsche Bank to "buy" from "hold" on valuation grounds. GSK has underperformed a buoyant pharmaceutical sector by around 20 percent in the past year

28 May 13 08:09

Tuesday broker round-up UPDATE

AG Barr: Investec increases target price from 562p to 591p, while downgrading from buy to add. Canaccord Genuity downgrades to hold with a target price of 570p. Amara Mining: Cantor Fitzgerald cuts target price from 81p to 63p and retains a buy recommendation. Compass Group: Nomura ups target pric

28 May 13 07:25

UPDATE 1-AstraZeneca buys heart firm Omthera for up to $443 mln

* AstraZeneca paying $12.70/share plus CVR worth up to $4.70 * Deal at 88 percent premium to Omthera price on Friday * Fish oil-based drug adds to AstraZeneca's heart business By Ben Hirschler LONDON, May 28 (Reuters) - AstraZeneca is to buy Omthera Pharmaceuticals for as

28 May 13 07:13

UPDATE 2-Elan rejects Royalty's $6.4 bln raised offer

* Elan says new bid continues to grossly undervalue company * Royalty cuts acceptance threshold from 90 pct previously * Irish firm's fate likely to be decided at June 17 meeting By Padraic Halpin DUBLIN, May 23 (Reuters) - Elan rejected Royalty Pharma's increased $6.4 bil

23 May 13 17:22

UPDATE 1-Royalty cuts acceptance bar for Elan bid to 50 pct

* Royalty cuts acceptance threshold from 90 pct previously * Elan board currently assessing new offer DUBLIN, May 23 (Reuters) - Royalty Pharma reduced the acceptance threshold for its increased $6.4 billion bid for Elan to 50 percent plus one share on Thursday as it sought to gather

23 May 13 12:00

RPT-FEATURE-Pfizer takes its shot at a vaccine for evasive superbug

By Julie Steenhuysen CHICAGO, May 23 (Reuters) - Kathrin Jansen is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped develop the $4 billion a year pneumonia and meningitis vaccine Prevnar 13

23 May 13 10:59

GSK flu shot may raise adult narcolepsy risk -Finnish scientists

HELSINKI/LONDON, May 23 (Reuters) - GlaxoSmithKline Plc's H1N1 pandemic flu shot may put adults at higher risk of developing narcolepsy, not only children as previous studies found, Finland's National Institute for Health and Welfare said on Thursday. Growing evidence of a link between GSK

23 May 13 10:52

FEATURE-Pfizer takes its shot at a vaccine for evasive superbug

By Julie Steenhuysen CHICAGO, May 23 (Reuters) - Kathrin Jansen is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped develop the $4 billion a year pneumonia and meningitis vaccine Prevnar 13

23 May 13 04:59

UPDATE 1-U.S. government taps GlaxoSmithKline for new antibiotics

* GSK to get up to $200 mln over five years under BARDA deal * Incentive for antibiotic R&D at time of rising resistance By Ben Hirschler LONDON, May 22 (Reuters) - The U.S. government has signed an antibiotics development deal worth up to $200 million with GlaxoSmithKline to ta

22 May 13 13:11

U.S. government taps GlaxoSmithKline for new antibiotics

LONDON, May 22 (Reuters) - The U.S. government has signed an antibiotics development deal worth up to $200 million with GlaxoSmithKline to tackle the dual threats of drug resistance and bioterrorism. The collaboration, the first of its kind between Washington and a drug company, will allow

22 May 13 11:01

Wednesday broker round-up UPDATE

Afferro Mining: Panmure Gordon reduces target price from 279p to 100p, while keeping its buy recommendation. Amara Mining: Westhouse Securities cuts target price from 110p to 90p retaining a buy recommendation. Amlin: Westhouse Securities moves target price from 455p to 470p and upgrades to add.

22 May 13 09:37

Immune system cancer drugs tipped to be a $35 bln market

* Potential sales of $35 bln a year over next 10 years - Citigroup * Immunotherapy may be used in up to 60 percent of cancers * Bristol-Myers Squibb and Roche both upgraded to "buy" By Ben Hirschler LONDON, May 22 (Reuters) - A new wave of medicines that tap the power of t

22 May 13 09:33

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.